Our technologies are completely unique in the industry and can be used to produce a wide array of products, each having specific characteristics and applications.
Products
Our Infuz2O displays fast and predictable onset and clearance times, Bio-Natural Oils display true strain specificity. Both technology platforms allow for controlled dosing with pharmacology comparable to oral medicines. APP technology provides the foundation to develop innovative combinations of these liquids with parallel preparations made from other medicinal plants and natural micronutrients such as vitamins and minerals.
The patent pending Aqueous Phytorecovery Process lays the foundation to isolate and develop new biopharmaceutical ingredients that will be produced from natural sources followed by chemical synthesis and metabolic pathway engineering.
Cannabis Beverage Opportunity
CURRENT BEVERAGE CHALLENGES
UNPREDICTABLE & LENGHTY ONSET
- Unpredictable onset of effects can cause dosage concerns
- Keeps many cannabis users on the sidelines from edibles and beverages
WATER-SOLUBLE BEVERAGE SOLUTIONS
HIGHLY PREDICTABLE & RAPID ONSET
- Less than 5 min onset is similar to alcohol
- Allows users to "self monitor" and control dosage in real-time
PROLONGED OFFSET
- 4 — 12 hour offset requires a "Full-day" commitment
- Does not allow for "casual" compsumption options
RAPID OFFSET
- Offset in 90 min or less does not require "full-day" commitment
- Enables a "casual" or "lunch time" consumption model
SINGLE FORMAT DOSAGE
- Limited revenue opportunity due to onset and offset
- Does not allow for a high-volume, low-price consumption model in one sitting — ie."6-Pack Model"
BUSINESS MODEL DRIVEN DOSAGE MODEL
- Ability to formulate low concentration formules at lower cost to drive volume sales — ie. "6-Pack model"
- Ability to formulatre high concentration single-shot dosage — ie. "Spirits" model
Infuz2O solves major hurdles and unlocks massive potential of the Cannabis Beverage Market
FORMULATED BEVERAGE
Balance
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Relaxation & Sleep
CANNABIS INGREDIENT
Hemp & GG#4 Infuz2O Blend
Enliven
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Mood uplifting & Focused energy
CANNABIS INGREDIENT
Girl Scout Cookies & GG#4 Infuz2O Blend
Relief
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Stress relief
CANNABIS INGREDIENT
Industrial Hemp Infuz2O
Balance
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Relaxation & Sleep
CANNABIS INGREDIENT
Hemp & GG#4 Infuz2O Blend
Enliven
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Mood uplifting & Focused energy
CANNABIS INGREDIENT
Girl Scout Cookies & GG#4 Infuz2O Blend
Relief
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Stress relief
CANNABIS INGREDIENT
Industrial Hemp Infuz2O
Cannabis / Hemp Water
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Delivers plant-specific benefits/experience
CANNABIS INGREDIENT
Single Cannabis or Hemp Infuz2O
PURE CANNABIS
Cannabis / Hemp Water
DOSAGE
60 ml (2 fl. oz.) — 1 serving
TYPE
Delivers plant-specific benefits/experience
CANNABIS INGREDIENT
Single Cannabis or Hemp Infuz2O
Superior Formulation
Our Infuz2O and Bio-Natural Oils have excellent flexibility when it comes to formulation. Infusion Biosciences has the technology and know-how necessary to create the next generation of superior formulations across every cannabis category that exists today.
SUPERIOR FORMULATION OPTIONS
APP Recovery Process can be formulated into any of the products available today in addition to proving the only truly water-soluble cannabis product
Biopharma
Innovation and Development of Phytopharmaceuticals
Infusion Biosciences (IB) is using a patent pending technology to produce water soluble phytochemicals from cannabis and hemp plant varieties. The water solutions produced from unique plants contain a distinct entourage of phytochemicals that are reported to provide medicinal benefits including relief from pain and anxiety, appetite control, and biochemical pathways underlying inflammation, liver diseases, and cancer. Adverse effects arising from current delivery methods (smoking, vaporization, and most edibles) limit prescription and non-prescription uses of phytochemicals from cannabis plants for medicinal purposes in a growing majority of individuals.
Current consumer products are limited to extracted oils that can only be delivered in vaporizers and selected edibles. Product benefit claims are now based on only determining a few cannabinoids without rigorous quality control analysis. The inability to deliver the current products in true water solutions is a major impediment to controlling the dose and reproducibility needed for desired nutritional and medicinal use of cannabis products. Water or beverage products are currently limited to the use of emulsifiers or oil nanoparticles and not true solutions in water. These not only limit proper delivery to the body but also prevent a broader acceptance of the current products.
There is a long history of successful development of biopharmaceutical drugs based on compounds isolated from plants and other natural sources. Phytochemical preparations produced from cannabis varieties hold significant promise as products to support a healthy and positive lifestyle to alleviate the side effects of traditional drug treatments or from chronic conditions that result in a lower quality of life.
IB’s strategy is built on the principles of biotechnology that witnessed the successful development of numerous naturally occurring molecules. Examples include insulin, therapeutic blood proteins (such as Factor VIII and antibodies), anti-anemia biopharmaceutical erythropoietin (originally isolated from human urine), and anticancer drugs from plants (such as taxol, homoharringtonine and camptothecin).
IB has completed the production of entourage of phytochemicals from multiple cannabis plant varieties and established bioactivities previously reported from smoking the oil-rich portions of these plants. The patent pending Aqueous Phytorecovery Process (APP) is effective in producing true water solutions of the bioactive molecules from multiple parts of the plants. The “liquid” cannabis preparations produced by APP display fast, predictable, and dose dependent effects in a large number of recreational and medicinal cannabis users. This is consistent with the pharmacology of orally administered bioactive molecules dissolved in water and is distinct from the administration of oil preparations that have become customary in the industry.